Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
0.7980
-0.0330 (-3.97%)
Mar 11, 2026, 11:40 AM EDT - Market open
Aprea Therapeutics Market Cap
Aprea Therapeutics has a market cap or net worth of $5.58 million as of March 11, 2026. Its market cap has decreased by -59.73% in one year.
Market Cap
5.58M
Enterprise Value
-7.91M
1-Year Change
-59.73%
Ranking
Category
Stock Price
$0.80
Market Cap Chart
Since May 27, 2022, Aprea Therapeutics's market cap has decreased from $18.94M to $5.58M, a decrease of -70.53%. That is a compound annual growth rate of -27.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 5.81M | -2.58% |
| Dec 31, 2025 | 5.97M | -66.64% |
| Dec 31, 2024 | 17.88M | 1.81% |
| Dec 29, 2023 | 17.56M | 0.11% |
| Dec 30, 2022 | 17.54M | -7.36% |
| May 27, 2022 | 18.94M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aptorum Group | 6.51M |
| Moolec Science | 6.51M |
| Processa Pharmaceuticals | 6.34M |
| Silexion Therapeutics | 6.13M |
| Aspire Biopharma Holdings | 6.03M |
| Purple Biotech | 6.02M |
| Quince Therapeutics | 5.93M |
| Psyence Biomedical | 5.85M |